Your browser doesn't support javascript.
loading
Healthcare Provider N95 Respirator Contamination Worn Behind Face Shields With SARS-CoV-2 During Routine Clinical Care of Patients With COVID-19.
Graves, Amanda M; Warren, Bobby G; Barrett, Aaron; Lewis, Sarah S; Smith, Becky; Weber, David J; Sickbert-Bennett, Emily E; Anderson, Deverick J.
Afiliación
  • Graves AM; Division of Infectious Diseases, Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina, USA.
  • Warren BG; Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
  • Barrett A; Division of Infectious Diseases, Disinfection, Resistance and Transmission Epidemiology (DiRTE) lab, Durham, North Carolina, USA.
  • Lewis SS; Division of Infectious Diseases, Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina, USA.
  • Smith B; Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
  • Weber DJ; Division of Infectious Diseases, Disinfection, Resistance and Transmission Epidemiology (DiRTE) lab, Durham, North Carolina, USA.
  • Sickbert-Bennett EE; Division of Infectious Diseases, Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina, USA.
  • Anderson DJ; Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
Open Forum Infect Dis ; 11(3): ofae040, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38449922
ABSTRACT
N95 respirator contamination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during clinical care of patients with coronavirus disease 2019 is poorly understood. We performed a prospective observational study on healthcare provider's (HCP's) N95 respirators' and face shields' SARS-CoV-2 contamination during aerosol-generating procedures on SARS-CoV-2-positive patients housed in a COVID-19-specific unit. Medical masks worn on top of HCP's N95 respirators, and under face shields, during study aerosol-generating procedures were used as surrogates to detect contamination to avoid waste. Thirty-three HCPs were studied, and a total of 33 mask and 27 face shields were sampled. Masks were cut into 9 pieces and face shields were sampled twice, front and back, to determine locality of contamination; however, no positive samples were identified using standard polymerase chain reaction techniques with a CT value up to 40. All 9 mask piece samples were then pooled, as were face shield samples, using centrifugal concentration with polyethersulfone membranes. Once pooled and concentrated, overall, 9 (15%) samples were positive via real-time polymerase chain reaction 5 from masks (15.2%) and 4 from face shields (14.8%).
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article